All registrants will be sent the webinar recording shortly following the completion of the session.
During this engaging session, you will:
Genitourinary oncologist focused on clinical and translational research and clinical trials in genitourinary malignancies including bladder, prostate and kidney cancer. Strong clinical background with a Doctor of Medicine (M.D.) from University of Chicago and training in Internal Medicine at the University of Michigan and Hematology/Oncology at Cleveland Clinic.
Mark leads the development and implementation of the organization’s research and policy agenda as well as overseeing the conduct of research projects to inform ongoing policy discussions. Mark establishes unique partnerships to help develop innovative policy proposals and consensus-driven solutions to address challenges and accelerate cancer drug development. He regularly participates in policy discussions and meetings throughout the year to help catalyze meaningful change for oncology healthcare.
Emilie Scherrer is the Senior Director and Head of Head of Strategy, HEOR at Tempus AI and is a member of the RWE Alliance. Emilie was previously the Global Director of Health Economics and Outcomes Research at Seagen. She has worked in biopharma (Amgen, Merck, Seagen, Pfizer) for a decade in roles across HEOR and RWE positions. She has extensive knowledge in designing and executing non-interventional, observational research studies for external dissemination (40+ publications) and regulatory submissions. Emilie earned an undergraduate degree from USC and a Masters in Health Economics from the London School of Economics / LSHTM.